AbbVie Launches $5B Buyback After Failed Deal
After scrapping a $55 billion merger attempt with British rival Shire PLC in the wake of a U.S. government crackdown on inversion deals, U.S. drugmaker AbbVie Inc. late Monday unveiled plans...To view the full article, register now.
Already a subscriber? Click here to view full article